Endometrial Neoplasms: all 1,347 studies

Page 5 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.

• Prehabilitation in Gynaecological Cancer PatientsRecruitingNCT04789694Phase 3
• Time Restricted Eating (TRE) Among Endometrial Cancer PatientsRecruitingNCT04783467Not applicable
• Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive SurgeryRecruitingNCT04774419Phase 2
• Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous CarcinomaRecruitingNCT04716686Phase 2
• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsRecruitingNCT04657068Phase 1/2
• Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin ToxicityRecruitingNCT04631731Phase 1/2
• A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or UbamatamabRecruitingNCT04590326Phase 1/2
• Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial CancerRecruitingNCT04586959Not applicable
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RecruitingNCT04585750Phase 1/2
• Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial CancersRecruitingNCT04570553Not applicable
• Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical CancerRecruitingNCT04567771Not applicable
• Mindfulness in Endometrial and Cervical CancerRecruitingNCT04512144Not applicable
• European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-IIIRecruitingNCT04504006
• Sentinel Node in Endometrial CancerRecruitingNCT04492995Phase 2
• A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial CancerRecruitingNCT04486352Phase 1/2
• Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial CancerRecruitingNCT04469764Phase 2
• Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial CancerRecruitingNCT04453904Not applicable
• The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.RecruitingNCT04403867
• Fertility Sparing Management of EndomeTrial Cancer and HyperplasiaRecruitingNCT04362046Not applicable
• A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor TypesRecruitingNCT04300556Phase 1/2
• Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their DiseaseRecruitingNCT04291612
• Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre ArchiveRecruitingNCT04290299
• DOvEEgene Fleur: New Uterine Sampling ToolRecruitingNCT04258449
• Adjuvant Stereotactic Pelvic Irradiation in Endometrial CancerRecruitingNCT04235179Phase 2
• 3 Year Recurrence Free Survival in Ultra-low-risk Endometrial CancerNot yet recruitingNCT04227249
• BP1001-A in Patients With Advanced or Recurrent Solid TumorsRecruitingNCT04196257Phase 1
• Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid MalignanciesRecruitingNCT04149691Phase 1
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasRecruitingNCT04104776Phase 1/2
• Sentinel Node Biopsy in Endometrial CancerRecruitingNCT04073706Phase 3
• Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the EndometriumRecruitingNCT04008563Not applicable
• Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic CancersRecruitingNCT03968406Phase 1
• Ketohexokinase Isoforms in Endometrial Cancer.RecruitingNCT03931265
• An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal StenosisRecruitingNCT03876860Not applicable
• Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial CancerRecruitingNCT03832361Phase 2
• Vaginal Cuff Brachytherapy Fractionation StudyRecruitingNCT03785288Phase 3
• RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial CancerRecruitingNCT03675893Phase 2
• PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial CancerRecruitingNCT03621904
• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) CancersRecruitingNCT03564340Phase 1/2
• Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer?RecruitingNCT03543215
• The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in TamponsRecruitingNCT03538665
• Value of LNG-IUS as Fertility-preserving Treatment of EAH and ECRecruitingNCT03463252Phase 2/3
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
• Endometrial Cancer Lymphadenectomy TrialRecruitingNCT03438474Not applicable
• Sentinel Node Mapping in High Risk Endometrial CancerRecruitingNCT03366051Not applicable
• Evaluation of the Fluorescent Green of Indocyanine in the Detection of Sentinel Lymph Node in Endometrial CancerRecruitingNCT03024398
• Biomarker Guided Treatment in Gynaecological CancerRecruitingNCT02543710Phase 4
• DOvEE - Diagnosing Ovarian & Endometrial Cancer EarlyRecruitingNCT02296307
• DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using GenomicsRecruitingNCT02288676
• Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
• Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor CellsAvailableNCT01267461
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerRecruitingNCT01174121Phase 2
• Specimen and Data Study for Ovarian Cancer Early Detection and PreventionRecruitingNCT00005095
• Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer SurvivorsCompletedNCT05796518Not applicableResults posted
• FitEx for Endometrial Cancer Survivors: Initial EfficacyCompletedNCT05737745Not applicableResults posted
• NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursTerminatedNCT05714553Phase 1/2Results posted
• A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid TumorsTerminatedNCT05572684Phase 1/2Results posted
• Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A MutationTerminatedNCT05523440Phase 2Results posted
• Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial CancerTerminatedNCT05263492Phase 2Results posted
• Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsTerminatedNCT05194735Phase 1/2Results posted
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsTerminatedNCT05169437Phase 2Results posted
• Michigan Genetic Hereditary Testing (MiGHT)CompletedNCT05162846Not applicableResults posted
• Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial CancerActive, not recruitingNCT05139368Not applicableResults posted
• Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN AlterationsTerminatedNCT05082025Phase 2Results posted
• A Study of PF-07260437 in Advanced or Metastatic Solid TumorsTerminatedNCT05067972Phase 1Results posted
• A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial CarcinomaTerminatedNCT05036681Phase 2Results posted
• MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)CompletedNCT05007106Phase 2Results posted
• Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension StudyCompletedNCT04865289Phase 3Results posted
• Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT04781088Phase 2Results posted
• Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial CancerCompletedNCT04763902Not applicableResults posted
• Study of Copanlisib and Ketogenic DietTerminatedNCT04750941Phase 2Results posted
• Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial CarcinomaTerminatedNCT04743999Phase 2Results posted
• Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial CancerCompletedNCT04719273Phase 2Results posted
• Adipocytokines in Endometrial CancerCompletedNCT04697264Results posted
• Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In GreeceCompletedNCT04696276Not applicableResults posted
• A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid TumorsTerminatedNCT04577963Phase 1/2Results posted
• The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) ApproachTerminatedNCT04527900Phase 2Results posted
• Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET ImagingTerminatedNCT04514692Phase 1/2Results posted
• ZW25 in Women With Endometrial CancersCompletedNCT04513665Phase 2Results posted
• Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial CancerTerminatedNCT04511026Phase 2Results posted
• Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial CancerActive, not recruitingNCT04269200Phase 3Results posted
• SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial CarcinomaCompletedNCT04205630Phase 2Results posted
• High Intensity Interval Training in Endometrial CancerCompletedNCT04025229Not applicableResults posted
• Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthCompletedNCT04000880Not applicableResults posted
• Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsCompletedNCT03935282Not applicableResults posted
• Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial CancerActive, not recruitingNCT03914612Phase 3Results posted
• Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001)CompletedNCT03884101Phase 3Results posted
• A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)Active, not recruitingNCT03835819Phase 2Results posted
• MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored FeedbackCompletedNCT03820024Not applicableResults posted
• Anxiety and Distress Levels in Women With Suspected Endometrial CancerCompletedNCT03813719Results posted
• Telehealth-Based Resistance Training Intervention for Endometrial Cancer SurvivorsCompletedNCT03722030Not applicableResults posted
• The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)CompletedNCT03694262Phase 2Results posted
• Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing HysterectomyActive, not recruitingNCT03671811Phase 2Results posted
• A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid TumorsCompletedNCT03665285Phase 1/2Results posted
• NR in Chemo-induced Peripheral NeuropathyTerminatedNCT03642990Phase 2Results posted
• Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial CancerCompletedNCT03617679Phase 2Results posted
• Rucaparib and Nivolumab in Patients With Prostate or Endometrial CancerTerminatedNCT03572478Phase 1/2Results posted
• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])CompletedNCT03517449Phase 3Results posted
• FPA150 in Patients With Advanced Solid TumorsTerminatedNCT03514121Early Phase 1Results posted
• ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial CancerTerminatedNCT03485729Phase 2Results posted
• Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or EndometriumCompletedNCT03476798Phase 2Results posted

← Endometrial Neoplasms overview